Lipid-Based Antimicrobial Delivery-Systems for the Treatment of Bacterial Infections

Da-Yuan Wang, Henny C. van der Mei*, Yijin Ren, Henk J. Busscher, Linqi Shi

*Corresponding author for this work

Research output: Contribution to journalReview articleAcademicpeer-review

9 Citations (Scopus)
70 Downloads (Pure)

Abstract

Many nanotechnology-based antimicrobials and antimicrobial-delivery-systems have been developed over the past decades with the aim to provide alternatives to antibiotic treatment of infectious-biofilms across the human body. Antimicrobials can be loaded into nanocarriers to protect them against de-activation, and to reduce their toxicity and potential, harmful side-effects. Moreover, antimicrobial nanocarriers such as micelles, can be equipped with stealth and pH-responsive features that allow self-targeting and accumulation in infectious-biofilms at high concentrations. Micellar and liposomal nanocarriers differ in hydrophilicity of their outer-surface and inner-core. Micelles are self-assembled, spherical core-shell structures composed of single layers of surfactants, with hydrophilic head-groups and hydrophobic tail-groups pointing to the micellar core. Liposomes are composed of lipids, self-assembled into bilayers. The hydrophilic head of the lipids determines the surface properties of liposomes, while the hydrophobic tail, internal to the bilayer, determines the fluidity of liposomal-membranes. Therefore, whereas micelles can only be loaded with hydrophobic antimicrobials, hydrophilic antimicrobials can be encapsulated in the hydrophilic, aqueous core of liposomes and hydrophobic or amphiphilic antimicrobials can be inserted in the phospholipid bilayer. Nanotechnology-derived liposomes can be prepared with diameters

Original languageEnglish
Article number872
Number of pages15
JournalFrontiers in Chemistry
Volume7
DOIs
Publication statusPublished - 10-Jan-2020

Keywords

  • bacterial biofilm
  • micelles
  • zeta potentials
  • hydrophobicity
  • lipids
  • liposomes
  • infection
  • fusogenicity
  • PSEUDOMONAS-AERUGINOSA
  • ANTIBACTERIAL ACTIVITY
  • LIPOSOMAL FORMULATION
  • CATIONIC LIPOSOMES
  • CONTROLLED-RELEASE
  • RESISTANT STRAINS
  • DRUG-DELIVERY
  • BIOFILM
  • NANOPARTICLES
  • PENETRATION

Cite this